Panel Discussion: Positioning mRNA Programmes to Attract Investment & Strategic Partnerships
8:00 am - Friday 19th February 2027
- Addressing investor expectations: balancing early-stage innovation with clinical validation requirements
- Understanding how political & regulatory headwinds impact RNA therapeutic investment (vaccine hesitancy, government funding changes)
- Navigating the tension between long-term scientific development & short-term investor exit timelines
